Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$16.50 – $19.00
74% from low
Exchange
OTC Link
OS
MEDIPAL HOLDINGS CRP ORD
No one on the platform currently holds MEPDF.
No tracked institution reports a position in MEPDF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $44.0000 | |
| 2026-09-30 | $44.0000 | |
| 2026-03-31 | $34.0000 | 2026-06-02 |
| 2025-09-30 | $32.0000 | 2025-12-02 |
| 2025-03-31 | $32.0000 | 2025-06-03 |
| 2024-09-30 | $30.0000 | 2024-12-03 |
| 2024-03-28 | $30.0000 | 2024-06-04 |
| 2023-09-29 | $30.0000 | 2023-12-04 |
No one on the platform has traded MEPDF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $4.02T | +5.2% | $1.29 | $1.27–$1.30 | 14.3× | 1 |
| 2028 | $4.12T | +2.4% | $1.34 | $1.33–$1.35 | 13.6× | 1 |
| 2029 | $4.20T | +2.0% | $1.34 | $1.33–$1.35 | 13.7× | 1 |
| 2030 | $4.33T | +2.9% | $1.56 | $1.55–$1.57 | 11.7× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | $0.28 | $0.41 | +44.4% |
| 2026-05-14 | $0.24 | $0.16 | -34.1% |
| 2026-02-09 | $0.32 | $0.48 | +48.3% |
| 2025-11-05 | $0.26 | $0.41 | +57.7% |
| 2025-08-05 | $0.32 | $0.32 | -0.6% |
| 2025-05-12 | $0.11 | $0.13 | +17.5% |
| 2025-02-10 | $0.22 | $0.44 | +100.5% |
| 2024-11-01 | $0.37 |
| $0.43 |
| +14.7% |
| +0.00% |
| $3.8B |
| — |
| RGEDFGedeon Richter PLC | $42.59 | +2.63% | $7.8B | — |
| SDGCFSundrug Co.,Ltd. | $28.18 | +0.00% | $3.3B | — |
Source: Financial Modeling Prep · peers by sector/industry